Cytotoxicity evaluation of curcumin-loaded affibody-decorated liposomes against breast cancerous cell lines.
Curcumin
HER2
affisome
breast cancer
targeted therapy
Journal
Journal of liposome research
ISSN: 1532-2394
Titre abrégé: J Liposome Res
Pays: England
ID NLM: 9001952
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
pubmed:
16
4
2020
medline:
29
10
2021
entrez:
16
4
2020
Statut:
ppublish
Résumé
Curcumin is known as an effective anticancer herbal medicine but unfortunately, its bioavailability is poor which necessitate efforts for developing more efficient and specific delivery systems. Human epidermal growth factor receptor 2 (HER 2) due to its overexpression in various types of cancers, is demonstrated to be a good candidate as a target for anticancer therapy. In this study, cytotoxicity of curcumin encapsulated in ZHER2:342 Affibody-decorated liposome was investigated against SKBR3 and MCF-7 cancerous cell lines. Curcumin-containing liposomes were prepared from soybeans lecetin and cholesterol by thin-film hydration method. Affibody ZHER2:342 molecules
Identifiants
pubmed: 32292087
doi: 10.1080/08982104.2020.1755981
doi:
Substances chimiques
Antineoplastic Agents
0
Liposomes
0
Curcumin
IT942ZTH98
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM